Same-day COVID-19 vaccines now available on a limited basis each day for eligible Seattle Children’s inpatients, ambulatory patients who are visiting the hospital for an appointment with their specialist and caregivers who are accompanying ambulatory patients to a same-day appointment.
Same-day appointments are dependent on vaccine availability and clinic capacity each day. We cannot guarantee them or schedule in advance. Read full post »
Seattle Children’s is pleased to announce the opening of a new mental health clinic for children and their families who primarily speak Spanish.
The clinic serves children ages 2 to 18 who have mental health concerns and their parents and other caregivers. Providers are bilingual.
The CALMA clinic (short for Child and Adolescent Latino Mental Health Assessment and Treatment) is held every Thursday and includes group therapy, which may be in the daytime or evening. Presently services are by telehealth only. Read full post »
Phlebotomy hours have changed at our regional clinics in Bellevue, Everett and Federal Way. Blood draws are now offered Monday through Friday from 8 a.m. to 4 p.m., closed evenings and weekends.
A new study published in Transgender Health found that gender-diverse youth who received gender-affirming healthcare during COVID-19 via telemedicine were satisfied with receiving care virtually. Dr. Gina Sequeira, co-director of the Gender Clinic at Seattle Children’s and the study’s lead author, says the study affirms telemedicine as a way to reduce the barriers to care these families typically experience, such as finding a local pediatric provider who offers gender-affirming care or the expense of trips to Seattle Children’s from distant locations. Read full post »
On March 17, Washington moved to the next phase of COVID-19 vaccination (Phase 1B, Tier 2), which means people who are 16 years and older with certain chronic conditions or disabilities are now eligible to receive the vaccine. Seattle Children’s will continue to serve as a community vaccination site and will offer vaccines through our public portal to all eligible members of the public, as supplies permit.
We are contacting our current patients ages 16 to 21 with certain chronic conditions or disabilities who meet the DOH vaccine eligibility criteria to offer a vaccine appointment. Read full post »
Seattle Children’s is vaccinating individuals who are eligible under Washington state’s Phase 1-A, priority groups 1 and 2, including:
- All workers at risk in healthcare settings except those who belong to another health system that is offering the vaccine.
- Community members who are eligible under state guidelines, when vaccine supplies permit.
Testing update
As of March 3, Seattle Children’s has tested 26,879 patients. 734 have tested positive or inconclusive, for a positivity rate of 2.7%. Approximately half of all positive patients are asymptomptic.
A new study published in JAMA Network Open shows that providing cognitive behavioral therapy (CBT) as part of a collaborative care model for youth who have experienced persistent post-concussive symptoms (PPCS) offers a promising treatment to alleviate symptoms and improve functioning.
Every year, an estimated 1.1 to 1.9 million youth suffer a sports-related concussion. Between 20% and 30% of those experience symptoms that last more than 30 days, including mental health challenges such as depression or anxiety. Yet there is a lack of high-quality evidence to guide best practices for the treatment of PPCS in the pediatric population. Read full post »
To better serve the Tri-Cities and surrounding region, Seattle Children’s Tri-Cities Clinic is moving to a larger, more centrally located clinic location opening March 11, 2021, in Kennewick, WA. The clinic will continue to offer the same pediatric specialties, with more room to help meet the growing need for specialty pediatric care in the region.
The new clinic in Kennewick will open Thursday, March 11, 2021, and will replace the clinic in Richland, WA, which will close for good at the end of the day on Thursday, March 4, 2021.
New Clinic Address: 8232 W. Grandridge Blvd., Kennewick, WA 99336 (near Costco)
Clinic and Appointments: 509-582-1700
Provider to Provider Line: 206-987-7777
Online: seattlechildrens.org/tri-cities Read full post »
The U.S. Food and Drug Administration has approved Bristol Myers Squibb’s Breyanzi, a chimeric antigen receptor (CAR) T-cell therapy used to treat adults with certain types of large B-cell lymphoma who have not responded to or who have relapsed after standard treatments.
The approval was supported by research at Seattle Children’s, including the CAR T-cell product, patient product manufacturing for Juno Therapeutics’ TRANSCEND trial and data from the Pediatric Leukemia Adoptive Therapy (PLAT-02) clinical trial.
Read more: “Cancer Research at Seattle Children’s Contributes to FDA Approval of CAR T-Cell Immunotherapy Treatment for Adults with Relapsed or Refractory Large B-Cell Lymphoma,” in On the Pulse, Feb. 8, 2021.
Seattle Children’s is currently in Phase 1-A of vaccine distribution, priority group 2. This means Seattle Children’s active community medical staff are now eligible to receive the COVID-19 vaccine at Seattle Children’s. We will let you when the vaccine is available to a wider group of community providers. Please note that community providers who are part of another health system should expect to get their vaccine with their home system rather than Seattle Children’s. Read full post »
